Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 6/20 | 0.44 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.44 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.44 |
| ▸ | MDK | P21741 | 3/20 | 0.43 |
| ▸ | BDNF | P23560 | 3/20 | 0.43 |
| ▸ | PTN | P21246 | 2/20 | 0.43 |
| ▸ | CD69 | Q07108 | 1/20 | 0.41 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.41 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.41 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | F10 | P00742 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12952583 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL15274904 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL12213976 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL15215584 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL18254178 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL12085239 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL25121361 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL15082697 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL4544701 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL21374694 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230321420-A1 | MICRONEEDLE ARRAY WITH ACTIVE INGREDIENT | ALLERGAN, INC. (US) | 2023-10-12 | — | — | US | disclosed |
| US-20170202982-A1 | Hyaluronic Acid-Based Nanoparticles as Biosensors for Imaging-Guided Surgery and Drug Delivery Vehicles and Methods Associated Therewith | WAKE FOREST UNIVERSITY | 2017-07-20 | — | — | US | disclosed |
| US-9662350-B2 | Pharmaceutical composition and method for inhibiting inflammation | CHINA MEDICAL UNIVERSITY (TW) | 2017-05-30 | — | — | US | disclosed |
| US-9549987-B2 | Glucose responsive hydrogel comprising PBA-grafted hyaluronic acid (HA) | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2017-01-24 | — | — | US | disclosed |
| US-20160096904-A1 | SUPERHYDROPHILIC AMPHIPHILIC COPOLYMERS AND PROCESSES FOR MAKING THE SAME | AKZO NOBEL CHEMICALS INT BV (NL) | 2016-04-07 | — | — | US | disclosed |
| US-9180161-B2 | CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorders | Sanford Burnham Prebys Medical Discovery Institute (US) | 2015-11-10 | — | — | US | disclosed |
| US-20150283247-A1 | GLUCOSE RESPONSIVE HYDROGEL COMPRISING PBA-GRAFTED HYALURONIC ACID (HA) | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2015-10-08 | — | — | US | disclosed |
| US-20150094279-A1 | PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITING INFLAMMATION | CHINA MEDICAL UNIVERSITY (TW) | 2015-04-02 | — | — | US | disclosed |
| US-20140274867-A1 | CLEANSING BARS COMPRISING SUPERHYDROPHILIC AMPHIPHILIC COPOLYMERS AND METHODS OF USE THEREOF | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20130196896-A1 | CAR PEPTIDE FOR HOMING, DIAGNOSIS & TARGETED THERAPY FOR PULMONARY AND FIBROTIC DISORDERS | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2013-08-01 | — | — | US | disclosed |
| US-20120034164-A1 | TRUNCATED CAR PEPTIDES AND METHODS AND COMPOSITIONS USING TRUNCATED CAR PEPTIDES | Sanford-Burnham Medical Research Institute California | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170202982-A1 | Hyaluronic Acid-Based Nanoparticles as Biosensors for Imaging-Guided Surgery and Drug Delivery Vehicles and Methods Associated Therewith | CD44, HLA-A, HLA-C | MAPK1 2043/4885LGALS3 15/4885LGALS8 24/4885 |
| US-20150283247-A1 | GLUCOSE RESPONSIVE HYDROGEL COMPRISING PBA-GRAFTED HYALURONIC ACID (HA) | CD44, PGD, SLC2A9 | MAPK1 281/4885LGALS3 337/4885LGALS8 905/4885 |
| US-20230321420-A1 | MICRONEEDLE ARRAY WITH ACTIVE INGREDIENT | CUTA, KRT18, MMP17 | MAPK1 1382/4885LGALS3 1959/4885LGALS8 682/4885 |
| US-20150094279-A1 | PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITING INFLAMMATION | CD44, IL17A, PROC | MAPK1 3472/4885LGALS3 311/4885LGALS8 416/4885 |
| US-20120034164-A1 | TRUNCATED CAR PEPTIDES AND METHODS AND COMPOSITIONS USING TRUNCATED CAR PEPTIDES | LNPEP, CD47, CARS1 | MAPK1 4124/4885LGALS3 263/4885LGALS8 304/4885 |
| US-20130196896-A1 | CAR PEPTIDE FOR HOMING, DIAGNOSIS & TARGETED THERAPY FOR PULMONARY AND FIBROTIC DISORDERS | CXCL12, CCL2, CCR9 | MAPK1 2838/4885LGALS3 308/4885LGALS8 621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.